This short comment suggests a connection, so far unrecognized, between two antitrust cases currently awaiting decision by the Supreme Court. In one case, the Court is likely, though not certain, to overturn the long-standing rule that resale price maintenance is illegal per se. If that should...

In several ways, traditional health care financing has long been unfair to middle and lower-income insureds. A major problem is monopoly pricing of many services and goods. Although the point is seldom recognized, American-style health insurance greatly aggravates the redistributive effects of...

While American policymakers and commentators have traditionally focused on three aspects of the health care system - access, cost, and quality - they have neglected an arguably coequal fourth issue: equity in the distribution of health care costs and benefits. This brief introduction to a...

This article explores the hypothesis that the U.S. health care system operates more like a robber baron than like Robin Hood, burdening ordinary payers of health insurance premiums disproportionately for the benefit of industry interests and higher-income consumer-taxpayers. Thus, lower- and...

For a reason not generally recognized – U.S.-style health insurance – health care providers with market power enjoy substantially more pricing freedom than comparable monopolists in other markets. Monopoly in health care markets therefore has redistributive effects that are especially...